Article ID Journal Published Year Pages File Type
8234598 International Journal of Radiation Oncology*Biology*Physics 2009 7 Pages PDF
Abstract
Radiation dose is an important predictor of FFbF in intermediate-risk prostate cancer. Treatment should continue to be individualized according to presenting disease characteristics until results from Radiation Therapy Oncology Group trial 0232 become available.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy
Authors
, , , , ,